3 Results for "

DD-03-171

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "DD-03-171" in MCE Product Catalog:

Cat. No.: HY-122830
CAS No.: 2366132-45-6
Purity:  98.72%
Target:  

PROTACs Btk NF-κB

Research Areas:  

Cardiovascular Disease Cancer

DD-03-171 is a PROTAC BTK degrader. DD-03-171 inhibits mantle cell lymphoma (MCL) cell proliferation (IC50 = 5.1 nM) and prolongs the survival of mice bearing a lymphoma PDX model by degrading BTK, IKFZ1, and IKFZ3. DD-03-171 also inhibits platelet function and thrombosis. (Pink: BTK ligand 9 (HY-168292); Black: linker (HY-28875); Blue: Thalidomide-NH-CH2-COOH (HY-131717)) .
loading...
    loading...
Cat. No.: HY-168292
CAS No.: 1709786-35-5
Research Areas:  

Cancer

BTK ligand 9 is a target protein ligand for BTK and can be used to synthesize PROTAC DD-03-171 (HY-122830) .
loading...
    loading...
Cat. No.: HY-168291
Research Areas:  

Cancer

Thalidomide-NH-CH2-CONH-C6-Br is an E3 ligase ligand-linker conjugate that can be used to synthesize DD-03-171 (HY-122830) .
loading...
    loading...